Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Assets (2024 - 2025)

Carlsmed (CARL) has disclosed Assets for 2 consecutive years, with $130.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets rose 151.08% year-over-year to $130.1 million, compared with a TTM value of $130.1 million through Dec 2025, up 151.08%, and an annual FY2025 reading of $130.1 million, up 151.08% over the prior year.
  • Assets was $130.1 million for Q4 2025 at Carlsmed, down from $134.9 million in the prior quarter.
  • Across five years, Assets topped out at $134.9 million in Q3 2025 and bottomed at $51.8 million in Q4 2024.